Bullous pemphigoid - I-Bullous Pemphigoid
I-Bullous Pemphigoid (Bullous pemphigoid) ibhekisa zonke iintlobo zokuphazamiseka kwesikhumba ezenza iibulla. "I-Bullous pemphigoid" yi-autoimmune pruritic isifo solusu ngokukhethekileyo kubantu abadala, abaneminyaka engaphezu kwe-60. Ukubunjwa kwamadyungudyungu kwindawo phakathi kwe-epidermal kunye ne-dermal skin layers kubonwa kwi-bullous pemphigoid.
☆ Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Ifoto ebonisa imilenze egutyungelwe ngamadyunguza, anokuchaphazela wonke umzimba.
Iimpawu zokuqala ngamanye amaxesha zikwimo ye-hives.
References
Pemphigus kunye bullous pemphigoid zizifo zolusu apho amadyungudyungu athi enzeka ngenxa ye-autoantibodies. Kwi- pemphigus , iiseli ezikumaleko wolusu olungaphandle kunye nenwebu eziphuma emlonyeni zilahlekelwa ukukwazi ukunamathelana, ngelixa kwi- pemphigoid , iiseli ezikumazantsi esikhumba ziphulukana nodibaniso lwazo kumaleko angaphantsi. Amadyungudyungu e pemphigus enziwa ngokuthe ngqo zizilwa-buhlungu ezizimelayo, ngelixa kwi- pemphigoid , amajoni omzimba abangela ukudumba ngokuvula umphelelisi. Iiprotheyini ezithile ezijoliswe kwezi autoantibodies zichongiwe: i-desmogleins kwi- pemphigus (ebandakanyeka kwi-cell adhesion) kunye neeprotheni kwi-hemidesmosomes kwi- pemphigoid (eziphi iiseli ze-anchor kumaleko angaphantsi) .
Pemphigus and bullous pemphigoid are autoantibody-mediated blistering skin diseases. In pemphigus, keratinocytes in epidermis and mucous membranes lose cell-cell adhesion, and in pemphigoid, the basal keratinocytes lose adhesion to the basement membrane. Pemphigus lesions are mediated directly by the autoantibodies, whereas the autoantibodies in pemphigoid fix complement and mediate inflammation. In both diseases, the autoantigens have been cloned and characterized; pemphigus antigens are desmogleins (cell adhesion molecules in desmosomes), and pemphigoid antigens are found in hemidesmosomes (which mediate adhesion to the basement membrane).
Pemphigus and bullous pemphigoid are autoantibody-mediated blistering skin diseases. In pemphigus, keratinocytes in epidermis and mucous membranes lose cell-cell adhesion, and in pemphigoid, the basal keratinocytes lose adhesion to the basement membrane. Pemphigus lesions are mediated directly by the autoantibodies, whereas the autoantibodies in pemphigoid fix complement and mediate inflammation. In both diseases, the autoantigens have been cloned and characterized; pemphigus antigens are desmogleins (cell adhesion molecules in desmosomes), and pemphigoid antigens are found in hemidesmosomes (which mediate adhesion to the basement membrane).
Bullous pemphigoid sesona sifo sixhaphakileyo se-autoimmune bullous, esichaphazela abantu abadala. Ukunyuka kwamatyala kumashumi eminyaka akutshanje kudityaniswa nabantu abalupheleyo, izehlo ezinxulumene neziyobisi, kunye neendlela eziphuculweyo zokuxilonga kwiindlela ezingezizo iinkunzi zesimo. Ibandakanya ukungasebenzi kakuhle kwi-T cell response kunye nokuveliswa kwe-autoantibodies (IgG kunye ne-IgE) ejolise kwiiprotheni ezithile (BP180 kunye ne-BP230) , okubangelwa ukuvuvukala kunye nokuchithwa kwesakhiwo senkxaso yesikhumba. Iimpawu zidla ngokubandakanya amadyungudyungu ekuphakameni, amabala arhawuzelelayo emzimbeni nasemilenzeni, kunye nokubandakanyeka okunqabileyo kwenwebu. Unyango ngokuyinhloko luxhomekeke kwi-topical kunye ne-systemic steroids, kunye nezifundo zamva nje ezibonisa inzuzo kunye nokhuseleko lonyango olongezelelweyo (doxycycline, dapsone, immunosuppressants) , olujoliswe ekunciphiseni ukusetyenziswa kwe-steroid.
Bullous pemphigoid is the most frequent autoimmune bullous disease and mainly affects elderly individuals. Increase in incidence rates in the past decades has been attributed to population aging, drug-induced cases and improvement in the diagnosis of the nonbullous presentations of the disease. A dysregulated T cell immune response and synthesis of IgG and IgE autoantibodies against hemidesmosomal proteins (BP180 and BP230) lead to neutrophil chemotaxis and degradation of the basement membrane zone. Bullous pemphigoid classically manifests with tense blisters over urticarial plaques on the trunk and extremities accompanied by intense pruritus. Mucosal involvement is rarely reported. High potency topical steroids and systemic steroids are the current mainstay of therapy. Recent randomized controlled studies have demonstrated the benefit and safety of adjuvant treatment with doxycycline, dapsone and immunosuppressants aiming a reduction in the cumulative steroid dose and mortality.
Bullous pemphigoid is the most frequent autoimmune bullous disease and mainly affects elderly individuals. Increase in incidence rates in the past decades has been attributed to population aging, drug-induced cases and improvement in the diagnosis of the nonbullous presentations of the disease. A dysregulated T cell immune response and synthesis of IgG and IgE autoantibodies against hemidesmosomal proteins (BP180 and BP230) lead to neutrophil chemotaxis and degradation of the basement membrane zone. Bullous pemphigoid classically manifests with tense blisters over urticarial plaques on the trunk and extremities accompanied by intense pruritus. Mucosal involvement is rarely reported. High potency topical steroids and systemic steroids are the current mainstay of therapy. Recent randomized controlled studies have demonstrated the benefit and safety of adjuvant treatment with doxycycline, dapsone and immunosuppressants aiming a reduction in the cumulative steroid dose and mortality.
